Health-related quality of life and adherence to hydroxyurea in adolescents and young adults with sickle cell disease

Pediatric Blood and Cancer

Volumn 64, Issue 6, 2017, Pages

  Badawy, Sherif M ^a,b,c   Thompson, Alexis A ^a,b   Lai, Jin Shei ^a   Penedo, Frank J ^a   Rychlik, Karen ^a   Liem, Robert I ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b CHILDREN'S MEMORIAL HOSPITAL   (United States)

^c ZAGAZIG UNIVERSITY   (Egypt)

Author keywords

adherence; adolescents; compliance; health related quality of life; hydroxyurea; patient reported outcomes; patient reported outcomes measurement information system; PROMIS ; sickle cell anemia; sickle cell disease; young adults

Indexed keywords

HEMOGLOBIN F; HYDROXYUREA;

ADOLESCENT; ADULT; ARTICLE; CHILD; COMPUTERIZED ADAPTIVE TESTING; CROSS-SECTIONAL STUDY; DEPRESSION; FATIGUE; FEASIBILITY STUDY; FEMALE; HEALTH CARE SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEAN CORPUSCULAR VOLUME; PATIENT COMPLIANCE; PATIENT-REPORTED OUTCOME; PRIORITY JOURNAL; QUALITY OF LIFE; SICKLE CELL ANEMIA; SOCIAL ISOLATION; ANEMIA, SICKLE CELL; CLINICAL TRIAL; MEDICATION COMPLIANCE; YOUNG ADULT;

ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; CHILD; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYDROXYUREA; MALE; MEDICATION ADHERENCE; QUALITY OF LIFE; YOUNG ADULT;

EID: 85006237829     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.26369     Document Type: Article

References (49)

1. National Heart, Lung and Blood Institute. 2012. What is sickle cell anemia? http://www.nhlbi.nih.gov/health/health-topics/topics/sca/. Accessed September 23, 2016
2. Rees DC, Williams TN, Gladwin MT. Sickle-cell disease. Lancet. 2010;376(9757):2018–2031.
3. Panepinto JA, Bonner M. Health-related quality of life in sickle cell disease: past, present, and future. Pediatr Blood Cancer. 2012;59(2):377–385.
4. Panepinto JA, Torres S, Bendo CB, et al. PedsQL multidimensional fatigue scale in sickle cell disease: feasibility, reliability, and validity. Pediatr Blood Cancer. 2014;61(1):171–177.
5. Ameringer S, Elswick RK, Jr., Smith W. Fatigue in adolescents and young adults with sickle cell disease: biological and behavioral correlates and health-related quality of life. J Pediatr Oncol Nurs. 2014;31(1):6–17.
6. Anderson LM, Allen TM, Thornburg CD, Bonner MJ. Fatigue in children with sickle cell disease: association with neurocognitive and social-emotional functioning and quality of life. J Pediatr Hematol Oncol. 2015;37(8):584–589.
7. Wang WC, Ware RE, Miller ST, et al. Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG). Lancet. 2011;377(9778):1663–1672.
8. Strouse JJ, Lanzkron S, Beach MC, et al. Hydroxyurea for sickle cell disease: a systematic review for efficacy and toxicity in children. Pediatrics. 2008;122(6):1332–1342.
9. Thornburg CD, Files BA, Luo Z, et al. Impact of hydroxyurea on clinical events in the BABY HUG trial. Blood. 2012;120(22):4304–4310.
10. Wang WC, Oyeku SO, Luo Z, et al. Hydroxyurea is associated with lower costs of care of young children with sickle cell anemia. Pediatrics. 2013;132(4):677–683.
11. Walsh KE, Cutrona SL, Kavanagh PL, et al. Medication adherence among pediatric patients with sickle cell disease: a systematic review. Pediatrics. 2014;134(6):1175–1183.
12. Thornburg CD, Calatroni A, Telen M, Kemper AR. Adherence to hydroxyurea therapy in children with sickle cell anemia. J Pediatr. 2010;156(3):415–419.
13. Patel NG, Lindsey T, Strunk RC, DeBaun MR. Prevalence of daily medication adherence among children with sickle cell disease: a 1-year retrospective cohort analysis. Pediatr Blood Cancer. 2010;55(3):554–556.
14. Thornburg CD, Calatroni A, Panepinto JA. Differences in health-related quality of life in children with sickle cell disease receiving hydroxyurea. J Pediatr Hematol Oncol. 2011;33(4):251–254.
15. Modi AC, Crosby LE. Barriers to treatment adherence for pediatric patients with sickle cell disease and their families. Children's Health Care. 2009;38(9):107–122.
16. Oyeku SO, Driscoll MC, Cohen HW, et al. Parental and other factors associated with hydroxyurea use for pediatric sickle cell disease. Pediatr Blood Cancer. 2013;60(4):653–658.
17. Badawy SM, Thompson AA, Liem RI. Technology access and smartphone app preferences for medication adherence in adolescents and young adults with sickle cell disease. Pediatr Blood Cancer. 2016;63(5):848–852.
18. Dobrozsi S, Panepinto J. Patient-reported outcomes in clinical practice. Hematology Am Soc Hematol Educ Program. 2015;2015(1):501–506.
19. Engelen V, Detmar S, Koopman H, et al. Reporting health-related quality of life scores to physicians during routine follow-up visits of pediatric oncology patients: is it effective? Pediatr Blood Cancer. 2012;58(5):766–774.
20. Engelen V, Koopman HM, Detmar SB, et al. Health-related quality of life after completion of successful treatment for childhood cancer. Pediatr Blood Cancer. 2011;56(4):646–653.
21. Wolfe J, Orellana L, Cook EF, et al. Improving the care of children with advanced cancer by using an electronic patient-reported feedback intervention: results from the PediQUEST randomized controlled trial. J Clin Oncol. 2014;32(11):1119–1126.
22. Glasgow RE, Kaplan RM, Ockene JK, Fisher EB, Emmons KM. Patient-reported measures of psychosocial issues and health behavior should be added to electronic health records. Health Aff (Millwood) 2012;31(3):497–504.
23. Berry DL, Blumenstein BA, Halpenny B, et al. Enhancing patient–provider communication with the electronic self-report assessment for cancer: a randomized trial. J Clin Oncol. 2011;29(8):1029–1035.
24. Dobrozsi SK, Panepinto JA. Patient-reported outcome measures identify impairment better than clinician documentation during pediatric cancer treatment. In: 57th American Society of Hematology Annual Meeting; 2015.
25. Myrvik MP, Beverung LM, Panepinto JA, Igler EC, Englebert N, Bingen KM. Integration of electronic patient-reported outcomes (ePROs) into pediatric clinic settings across hematology/oncology/bone marrow transplant. Clin Pract Pediatr Psychol. 2014;2(1):39–49.
26. Quinn H, Thissen D, Liu Y, et al. Using item response theory to enrich and expand the PROMIS(R) pediatric self report banks. Health Qual Life Outcomes. 2014;12:160.
27. Lai JS, Butt Z, Zelko F, et al. Development of a parent-reported cognitive function item bank using item response theory and exploration of its clinical utility in computerized adaptive testing. J Pediatr Psychol. 2011;36(7):766–779.
28. Irwin DE, Stucky BD, Thissen D, et al. Sampling plan and patient characteristics of the PROMIS pediatrics large-scale survey. Qual Life Res. 2010;19(4):585–594.
29. Cella D, Riley W, Stone A, et al. The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005–2008. J Clin Epidemiol. 2010;63(11):1179–1194.
30. Lai JS, Stucky BD, Thissen D, et al. Development and psychometric properties of the PROMIS((R)) pediatric fatigue item banks. Qual Life Res. 2013;22(9):2417–2427.
31. DeWalt DA, Gross HE, Gipson DS, et al. PROMIS((R)) pediatric self-report scales distinguish subgroups of children within and across six common pediatric chronic health conditions. Qual Life Res. 2015;24(9):2195–2208.
32. Varni JW, Magnus B, Stucky BD, et al. Psychometric properties of the PROMIS (R) pediatric scales: precision, stability, and comparison of different scoring and administration options. Qual Life Res. 2014;23(4):1233–1243.
33. Dampier C, Barry V, Gross HE, et al. Initial evaluation of the Pediatric PROMIS(R) health domains in children and adolescents with sickle cell disease. Pediatr Blood Cancer. 2016;63(6):1031–1037.
34. Dampier C, Jaeger B, Gross HE, et al. Responsiveness of PROMIS pediatric measures to hospitalizations for sickle pain and subsequent recovery. Pediatr Blood Cancer. 2016;63(6):1038–1045.
35. Thissen D, Liu Y, Magnus B, et al. Estimating minimally important difference (MID) in PROMIS pediatric measures using the scale-judgment method. Qual Life Res. 2016;25(1):13–23.
36. Yost KJ, Eton DT, Garcia SF, Cella D. Minimally important differences were estimated for six Patient-Reported Outcomes Measurement Information System-Cancer scales in advanced-stage cancer patients. J Clin Epidemiol. 2011;64(5):507–516.
37. Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008;10(5):348–354.
38. Krousel-Wood M, Islam T, Webber LS, Re RN, Morisky DE, Muntner P. New medication adherence scale versus pharmacy fill rates in seniors with hypertension. Am J Manag Care. 2009;15(1):59–66.
39. Detmar SB, Muller MJ, Schornagel JH, Wever LD, Aaronson NK. Health-related quality-of-life assessments and patient–physician communication: a randomized controlled trial. JAMA. 2002;288(23):3027–3034.
40. Velikova G, Booth L, Smith AB, et al. Measuring quality of life in routine oncology practice improves communication and patient well-being: a randomized controlled trial. J Clin Oncol. 2004;22(4):714–724.
41. NIH-PROMIS. 2016. PROMIS® Computer Adaptive Test (CAT). http://www.nihpromis.org/software/demonstration. Accessed September 23, 2016
42. Dampier C, Lieff S, LeBeau P, et al. Health-related quality of life in children with sickle cell disease: a report from the Comprehensive Sickle Cell Centers Clinical Trial Consortium. Pediatr Blood Cancer. 2010;55(3):485–494.
43. Palermo TM, Schwartz L, Drotar D, McGowan K. Parental report of health-related quality of life in children with sickle cell disease. J Behav Med. 2002;25(3):269–283.
44. Panepinto JA, O'Mahar KM, DeBaun MR, Loberiza FR, Scott JP. Health-related quality of life in children with sickle cell disease: child and parent perception. Br J Haematol. 2005;130(3):437–444.
45. Panepinto JA, Pajewski NM, Foerster LM, Hoffmann RG. The performance of the PedsQL generic core scales in children with sickle cell disease. J Pediatr Hematol Oncol. 2008;30(9):666–673.
46. Amr MA, Amin TT, Al-Omair OA. Health related quality of life among adolescents with sickle cell disease in Saudi Arabia. Pan Afr Med J. 2011;8:10.
47. Dale JC, Cochran CJ, Roy L, Jernigan E, Buchanan GR. Health-related quality of life in children and adolescents with sickle cell disease. J Pediatr Health Care. 2011;25(4):208–215.
48. Ballas SK, Barton FB, Waclawiw MA, et al. Hydroxyurea and sickle cell anemia: effect on quality of life. Health Qual Life Outcomes. 2006;4:59.
49. Vreeman RC, Wiehe SE, Pearce EC, Nyandiko WM. A systematic review of pediatric adherence to antiretroviral therapy in low- and middle-income countries. Pediatr Infect Dis J. 2008;27(8):686–691.